Cargando…

Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression

CONTEXT: Aidi injection (ADI), a traditional Chinese medicine antitumor injection, is usually combined with doxorubicin (DOX) for the treatment of malignant tumours. The cardiotoxicity of DOX is ameliorated by ADI in the clinic. However, the relevant mechanism is unknown. OBJECTIVE: To investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yuan, Liu, Wen, Lv, Ting, Wang, Yanli, Liu, Ting, Chen, Yi, Jin, Yang, Huang, Jin, Zheng, Lin, Huang, Yong, He, Yan, Li, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397428/ https://www.ncbi.nlm.nih.gov/pubmed/35980105 http://dx.doi.org/10.1080/13880209.2022.2110127

Ejemplares similares

Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
por: Lu, Yuan, et al.
Publicado: (2021)

Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation
por: Zhuang, Zhenjie, et al.
Publicado: (2021)

Aidi Injection as Adjuvant Drug Combined with Chemotherapy in Treatment of Breast Cancer: A Systematic Meta-Analysis
por: Wu, Chenhao, et al.
Publicado: (2021)

Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity
por: Sonowal, Himangshu, et al.
Publicado: (2017)

Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer
por: Zhao, Hua-Ye, et al.
Publicado: (2016)

Effect of Aidi Injection plus TACE on Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
por: Dai, Yaoyao, et al.
Publicado: (2018)

A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis
por: Chen, Ting, et al.
Publicado: (2017)

Efficacy of Aidi Injection and Brucea javanica Oil Emulsion Injection in Rectal Cancer during CapeOX Adjuvant Chemotherapy
por: Meng, Wenjun, et al.
Publicado: (2021)

Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments
por: Wang, Haojia, et al.
Publicado: (2023)

Anti-metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial-mesenchymal transition and angiogenesis
por: Shi, Qingtong, et al.
Publicado: (2018)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017)

Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis
por: Dou, Dou, et al.
Publicado: (2020)

Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity
por: He, Quan, et al.
Publicado: (2020)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Aidi injection combined with chemotherapy in the treatment of cancer patients: a systematic review of systematic reviews and meta-analyses
por: Zhao, Dehua, et al.
Publicado: (2021)

Efficacy and Safety of Aidi Injection as an Adjuvant Therapy on Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Chai, Yihui, et al.
Publicado: (2020)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

Lipid Emulsion Inhibits the Late Apoptosis/Cardiotoxicity Induced by Doxorubicin in Rat Cardiomyoblasts
por: Subbarao, Raghavendra Baregundi, et al.
Publicado: (2018)

Didymin attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress
por: Chen, Rongchang, et al.
Publicado: (2021)

Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis
por: Gu, Yue, et al.
Publicado: (2018)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice
por: Li, Jun, et al.
Publicado: (2019)

PKC-ζ Aggravates Doxorubicin-Induced Cardiotoxicity by Inhibiting Wnt/β-Catenin Signaling
por: Cao, Yan-Jun, et al.
Publicado: (2022)

Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Aidi Injection Treating of Nonsmall Cell Lung Cancer
por: Zhang, Weizhou, et al.
Publicado: (2022)

Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity
por: Jiang, Jiangsong, et al.
Publicado: (2017)

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
por: Fan, Rui, et al.
Publicado: (2023)

Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation
por: Zhang, Lei, et al.
Publicado: (2022)

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
por: Zhang, Sheng, et al.
Publicado: (2019)

UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity
por: An, Lin, et al.
Publicado: (2017)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials
por: Wang, Cheng-Qiong, et al.
Publicado: (2021)

A Novel Carbonyl Reductase with Anti-Prelog Stereospecificity from Acetobacter sp. CCTCC M209061: Purification and Characterization
por: Chen, Xiao-Hong, et al.
Publicado: (2014)

Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo
por: Zheng, Ke, et al.
Publicado: (2015)

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang, Lili, et al.
Publicado: (2019)

PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
por: Zhou, Min, et al.
Publicado: (2022)

A short‐chain carbonyl reductase mutant is an efficient catalyst in the production of (R)‐1,3‐butanediol
por: Guo, Xiaoyan, et al.
Publicado: (2023)

Involvement of Abnormal Gut Microbiota Composition and Function in Doxorubicin-Induced Cardiotoxicity
por: Huang, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5p8ocfne6o8362344221loqis3